Sociedad Química y Minera de Chile S.A. SQM · NYSE
$62.01 -2.97% (-$1.90)
Summary
69 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 21 USD is left as net profit.
- It earns 12 USD a year on every 100 USD of invested capital.
- Analysts expect revenue to grow by 88% this fiscal year.
What to watch
- Revenue fell by 25% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It missed profit estimates 7 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Chemicals - Specialty)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.1 USD for 1 USD of yearly profit. Over the last five years it was 18.1 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 20% a year over 5 years. Over the last 3 years it fell by 25% a year. For the next fiscal year analysts expect revenue to grow by 88%. Earnings per share fell by 47% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 58 USD
- Sales and administration 3.2 USD
- Taxes and other 18 USD
- Net profit 21 USD
Net profit, industry median (Chemicals - Specialty) 4.0 USD
Out of every 100 USD of revenue, 21 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.84%
- Paid out of profit
- 50%
You receive $2.45 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 8
- Sell 3
Today's price within the analysts' price targets
The average target of $93.33 is 51% above today's price. 31% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Lithium and Derivatives 50%
- Iodine And Derivatives 23%
- Specialty plant nutrition 21%
- Potassium 3.4%
- Industrial Chemicals 1.6%
- Other 0.7%
By region
- Asia and others Country 63%
- North America Country 15%
- Europe Country 14%
- Latin America and the Caribbean Country 4.1%
- Chile Country 3.5%
Lithium and Derivatives brings in 50% of revenue.
Segments in detail